|Bid||0.00 x 900|
|Ask||0.00 x 1300|
|Day's Range||82.20 - 83.57|
|52 Week Range||65.25 - 92.64|
|Beta (5Y Monthly)||0.47|
|PE Ratio (TTM)||20.21|
|Earnings Date||Oct 27, 2020|
|Forward Dividend & Yield||2.44 (2.94%)|
|Ex-Dividend Date||Sep 14, 2020|
|1y Target Est||95.94|
You’ve probably been wondering how the Food and Drug Administration will decide if a COVID-19 vaccine is safe and effective.
COMPANY CLOSE UPDATES Terrence Horan Shares of Johnson & Johnson JNJ slid 0.61% to $144.21 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 1.
A coming rival will be Regeneron, whose presentation showed that its immuno-oncology drug Libtayo reduced deaths in lung cancer patients by 43%, compared with chemo, during an 11-month treatment.